GF Fund Management’s Boston Scientific BSX Stock Holding History

GF Fund Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.56M	Hold	40,749	–	–	0.04%	157
2025 Q4	$3.89M	Sell	40,749 -769	-2%	-$75.4K	0.07%	150
2025 Q3	$4.05M	Buy	41,518 +10,498	+34%	+$1.09M	0.07%	152
2025 Q2	$3.33M	Sell	31,020 -232	-0.7%	-$23.5K	0.07%	164
2025 Q1	$3.15M	Hold	31,252	–	–	0.07%	159
2024 Q4	$2.79M	Buy	+31,252	New	+$2.75M	0.06%	163

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GF Fund Management's BSX Position: Q1 2026 in Review

GF Fund Management held its Boston Scientific (BSX) position steady in Q1 2026 at 40,749 shares worth $2.56M. The position accounts for 0.04% of the portfolio, ranked #157.

GF Fund Management first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.05M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

GF Fund Management held 40,749 shares of Boston Scientific worth $2.56M as of Q1 2026.
GF Fund Management left its Boston Scientific share count unchanged in Q1 2026.
Boston Scientific made up 0.04% of GF Fund Management's portfolio in Q1 2026, its #157 holding.
GF Fund Management first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
GF Fund Management's Boston Scientific position peaked at $4.05M in Q3 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.